Tocilizumab in COVID-19: some clarity amid controversy

0
184
Tocilizumab in COVID-19: some clarity amid controversy
Tocilizumab in COVID-19: some clarity amid controversy

Hyperactivation of the immune response, together with launch of pro-inflammatory cytokines corresponding to interleukin-6 (IL-6), may play a key function within the pathophysiology of extreme sickness from COVID-19.

  • Del Valle DM
  • Kim-Schulze S
  • Huang HH
  • et al.
An inflammatory cytokine signature predicts COVID-19 severity and survival.